Industries
Drugs / Biologics
Medical & Surgical
Food
SOX Compliance
IT Control and PCI
Customer Support
Call: 800-447-9407
Fax: 302-288-6884
support@globalcompliancepanel.com
News
...more news

  Home > Speaker Profile

Speaker Profile


John E Lincoln
Consultant, Medical device and Regulatory affairs,

John E. Lincoln is a medical device and regulatory affairs consultant. He has helped companies to implement or modify their GMP systems and procedures, product risk management, U.S. FDA responses. In addition, he has successfully designed, written and run all types of process, equipment and software qualifications/validations, which have passed FDA audit or submission scrutiny, and described in peer-reviewed technical articles, and workshops, world wide. John has also managed pilot production, regulatory affairs, product development/design control, 510(k) submissions, risk management per ISO 14971, and projects; with over 28 years of experience in the FDA-regulated medical products industry - working with start-ups to Fortune 100 companies, including Abbott Laboratories, Hospira, Tyco/Mallinckrodt. He is a graduate of UCLA.

Upcoming Webinars
Design History File, and Technical File / Design Dossier - A Regulatory Overview
This webinar will examine both the FDA and MDD regulatory expectations for the respective DHF and TF / DD.
Live  Wednesday, September 22, 2010 10:00 AM PDT | 01:00 PM EDT,  Duration:60 Minutes
$245.00
...more

Recorded Webinars
Risk-Based CAPA Systems
CAPA, Corrective and Preventive Action, is a major element of cGMP compliance, and key source of regulatory problems.
Recorded ,
$295.00

Changes and the 510(k)
The majority of medical devices are cleared for marketing in the U.S. by the FDA under the 510(k) process.
Recorded ,
$295.00

Best Selling Medical Device Webinars by John E. Lincoln
CompliancePanel brings you a special offer on Medical Device Recorded Webinars.
Recorded asd,
$795.00

Master Verification and Validation Planning to Meet US FDA, ISO 13485 and 14971 Requirements
FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in many companies.
Recorded ,
$295.00

Avoid Warning Letters in View of the U.S. FDA’s Stated Goal to Increase Their Use
FDA Warning Letters and recent high-profile recalls indicate major cGMP deficiencies in many companies.
Recorded ,
$295.00

The Design History File and the Technical File / Design Dossier
The DHF is a key element of Design Control under the GMPs, and is a major subject for review during a U.S FDA compliance audit.
Recorded ,
$295.00

Product Risk Management - ISO 14971:2007
This webinar will address the use of the ISO 14971 model to perform and document such activities and the additional actions necessary to make it a useful product reference and training tool.
Recorded ,
$295.00

Risk-based Software Verification and Validation
This webinar will address the use of the FDA, GAMP, and other applicable industry software validation models, coupled with the ISO 14971 model to structure, run, and document acceptable software validations.
Recorded ,
$295.00

Root Cause Analysis – Starting at the Beginning
Root Cause Analysis (RCE) is a major tool in product complaint, non-conformance, and OOS failure investigations, and hazard analysis / risk management and mitigation activities.
Recorded ,
$295.00

Meet the New, Tougher FDA Expectations
The last few years have seen the U.S. FDA come under increasing negative public scrutiny.
Recorded ,
$295.00

Setting Up and Running a Tougher Supplier Audit Program
The last few years have seen the U.S. FDA come under increasing negative public scrutiny.
Recorded ,
$295.00

Drafting a Software V&V Documentation Package and Protocol
The verification and validation of medical software is coming under increased scrutiny by the U.S. FDA.
Recorded ,
$295.00

Device Changes and the 510(k)
The majority of medical devices are cleared for marketing in the U.S. by the FDA under the 510(k) process.
Recorded ,
$295.00

Process Verification / Validation Under HACCP, the cGMPS and ISO
FDA Warning Letters and recent recalls in the media show major cGMP deficiencies in companies' validation activities.
Recorded ,
$295.00

Product Risk Management Under ISO 14971:2007 and ICH Q9
The U.S. FDA has stated that the use of a medical device or pharmaceuticals entails some degree of risk.
Recorded ,
$295.00

Master Verification and Validation Planning Under the cGMPS and ISO 13485
FDA Warning Letters and recent recalls in the media show major cGMP deficiencies in companies' validation activities.
Recorded ,
$295.00

Change Control - The Achilles Heel of cGMP Compliance
The last few years have seen an increase in product recalls. For this and other reasons, the U.S. FDA come under increasing negative public scrutiny.
Recorded ,
$295.00

Webinar on CAPA Challenges
CAPA, Corrective and Preventive Action, is a major element of cGMP compliance. Sadly, it is also a key source of regulatory problems.
Recorded ,
$295.00

The DHF, Technical File and Design Dossier - Similarities, Differences and The Future
This webinar will examine the existing and proposed requiements for the FDA's DHF and the MDD's TF/DD. Differing purposes / goals.
Recorded ,
$295.00

Meeting Tougher U.S. FDA Expectations - Update
This webinar will examine the stated intent of the Agency to get tougher across the board in its expectations for the medical industry and its compliance to the cGMPs.
Recorded ,
$295.00

Key Modules of an Effective CAPA SOP
This webinar will examine the stated intent of the Agency to get tougher across the board in its expectations for the medical industry and its compliance to the cGMPs, especially CAPA.
Recorded ,
$295.00

Design History File, and Technical File / Design Dossier - A Regulatory Overview
This webinar will examine both the FDA and MDD regulatory expectations for the respective DHF and TF / DD.
Recorded ,
$295.00
...more